ATE188129T1 - Ipriflavone enthaltende pharmazeutische zubereitungen und deren verwendung zur ersetzung von knochendefekten - Google Patents

Ipriflavone enthaltende pharmazeutische zubereitungen und deren verwendung zur ersetzung von knochendefekten

Info

Publication number: ATE188129T1
Authority: AT; Austria
Prior art keywords: ipriflavone; bone defects; pharmaceutical preparations; preparations containing; tricalcium phosphate
Prior art date: 1993-08-02

Application number

AT94111951T

Other languages

English (en)

Inventor

Laszlo Dr Prezmeczky

Dr Gusztav Klenk

Ms Erzsebet Englovszky

Dr Tibor Horvath

Dr Laszlo Miszkiewicz

Dr Gabor Szekacs

Dr Ferenc Levai

Nee Morvai Mrs Magdoln Vitanyi

Original Assignee

Prezmecky Laszlo Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-02

Filing date

1994-08-01

Publication date

2000-01-15

1994-08-01 Application filed by Prezmecky Laszlo Dr filed Critical Prezmecky Laszlo Dr

2000-01-15 Application granted granted Critical

2000-01-15 Publication of ATE188129T1 publication Critical patent/ATE188129T1/de

Links

SFBODOKJTYAUCM-UHFFFAOYSA-N Ipriflavone Chemical compound C=1C(OC(C)C)=CC=C(C2=O)C=1OC=C2C1=CC=CC=C1 SFBODOKJTYAUCM-UHFFFAOYSA-N 0.000 title abstract 5
229960005431 ipriflavone Drugs 0.000 title abstract 5
210000000988 bone and bone Anatomy 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000001506 calcium phosphate Substances 0.000 abstract 3
229910052588 hydroxylapatite Inorganic materials 0.000 abstract 3
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 3
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 3
229940078499 tricalcium phosphate Drugs 0.000 abstract 3
229910000391 tricalcium phosphate Inorganic materials 0.000 abstract 3
235000019731 tricalcium phosphate Nutrition 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
230000007547 defect Effects 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
230000011164 ossification Effects 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/54—Filling; Sealing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Transplantation (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Plastic & Reconstructive Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Dental Preparations (AREA)

AT94111951T 1993-08-02 1994-08-01 Ipriflavone enthaltende pharmazeutische zubereitungen und deren verwendung zur ersetzung von knochendefekten ATE188129T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU9302230A HU212932B (en)	1993-08-02	1993-08-02	Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Publications (1)

Publication Number	Publication Date
ATE188129T1 true ATE188129T1 (de)	2000-01-15

Family

ID=10983854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94111951T ATE188129T1 (de)	1993-08-02	1994-08-01	Ipriflavone enthaltende pharmazeutische zubereitungen und deren verwendung zur ersetzung von knochendefekten

Country Status (14)

Country	Link
US (1)	US5571186A (de)
EP (1)	EP0638321B1 (de)
JP (1)	JP3500190B2 (de)
KR (1)	KR950005313A (de)
CN (1)	CN1208093C (de)
AT (1)	ATE188129T1 (de)
AU (1)	AU686632B2 (de)
CA (1)	CA2129279A1 (de)
DE (1)	DE69422346T2 (de)
DK (1)	DK0638321T3 (de)
ES (1)	ES2142893T3 (de)
HU (1)	HU212932B (de)
LV (1)	LV10580B (de)
NZ (1)	NZ264152A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU9502198D0 (en) *	1995-07-21	1995-09-28	Chinoin Gyogyszer Es Vegyeszet	Novel indication
CN101646433B (zh)	2006-10-24	2011-11-16	戴维·W·克雷姆平	抗再吸收的和造骨的食物增补剂和使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3949085A (en) *	1970-05-27	1976-04-06	Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt	Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
HU162377B (de) *	1970-05-27	1973-02-28
JPS59199630A (ja) *	1983-04-26	1984-11-12	Takeda Chem Ind Ltd	卵巣機能低下症治療剤
HU199444B (en) *	1985-09-10	1990-02-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
HU201474B (en) *	1987-02-03	1990-11-28	Tibor Balogh	Process for producing new dentriatrical composition
US5124325A (en) *	1989-06-13	1992-06-23	Kyorin Pharmaceutical Co., Ltd.	Therapeutic agents of metabolic bone disease
IT1241079B (it) *	1990-03-23	1993-12-29	Chiesi Farma Spa	Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
US5164187A (en) *	1990-04-05	1992-11-17	Norian Corporation	Hydroxyapatite prosthesis coatings
IT1244697B (it) *	1991-02-01	1994-08-08	Chiesi Farma Spa	Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

1993
- 1993-08-02 HU HU9302230A patent/HU212932B/hu active IP Right Revival
1994
- 1994-07-29 LV LVP-94-150A patent/LV10580B/en unknown
- 1994-07-29 AU AU68810/94A patent/AU686632B2/en not_active Ceased
- 1994-07-29 US US08/282,753 patent/US5571186A/en not_active Expired - Lifetime
- 1994-08-01 ES ES94111951T patent/ES2142893T3/es not_active Expired - Lifetime
- 1994-08-01 EP EP94111951A patent/EP0638321B1/de not_active Expired - Lifetime
- 1994-08-01 DE DE69422346T patent/DE69422346T2/de not_active Expired - Fee Related
- 1994-08-01 KR KR1019940019026A patent/KR950005313A/ko not_active Abandoned
- 1994-08-01 DK DK94111951T patent/DK0638321T3/da active
- 1994-08-01 AT AT94111951T patent/ATE188129T1/de not_active IP Right Cessation
- 1994-08-02 CN CNB941161919A patent/CN1208093C/zh not_active Expired - Fee Related
- 1994-08-02 CA CA002129279A patent/CA2129279A1/en not_active Abandoned
- 1994-08-02 NZ NZ264152A patent/NZ264152A/en unknown
- 1994-08-02 JP JP18141294A patent/JP3500190B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ264152A (en)	1996-08-27
AU686632B2 (en)	1998-02-12
EP0638321A1 (de)	1995-02-15
JPH07144018A (ja)	1995-06-06
DE69422346T2 (de)	2000-07-27
EP0638321B1 (de)	1999-12-29
CN1105271A (zh)	1995-07-19
JP3500190B2 (ja)	2004-02-23
LV10580A (lv)	1995-04-20
KR950005313A (ko)	1995-03-20
ES2142893T3 (es)	2000-05-01
HUT71253A (en)	1995-11-28
HU9302230D0 (en)	1993-10-28
AU6881094A (en)	1995-02-09
DK0638321T3 (da)	2000-06-19
CN1208093C (zh)	2005-06-29
LV10580B (en)	1995-10-20
HU212932B (en)	1996-12-30
DE69422346D1 (de)	2000-02-03
US5571186A (en)	1996-11-05
CA2129279A1 (en)	1995-02-03

Legal Events

Date	Code	Title	Description
2000-07-15	UEP	Publication of translation of european patent specification
2009-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
NO971563L (no)	1997-04-04	Ny anvendelse av bioaktivt silikaglass og nye sammensetninger som inneholder bioaktivt silikaglass
DE69432596D1 (de)	2003-06-05	Zusammensetzungen für verabreichung von osteogenen proteinen
ATE174872T1 (de)	1999-01-15	Carbonierte hydroxyapatit-zusammensetzungen und ihre verwendungen
AU8452991A (en)	1992-03-26	1-aryl-3-pyridinyl-2-propene-1-ones
ATE103189T1 (de)	1994-04-15	Chirurgisches material und verwendung des materials zur herstellung (eines teiles) einer anordnung zur verwendung in der knochenchirurgie.
ATE153535T1 (de)	1997-06-15	Tgf-beta zusammensetzung zum herbeiführen von knochenwachstum
PT98889A (pt)	1992-07-31	Processo para a preparacao de material para proteses osseas a base de produtos ceramicos osseos
ATE79763T1 (de)	1992-09-15	Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
AU6567086A (en)	1987-05-28	Compositions and methods for the treatment of bleeding disorders
ATA186692A (de)	1997-09-15	Pharmazeutische zusammensetzung
ES2009561A6 (es)	1989-10-01	Procedimiento para la preparacion de una nueva composicion dental.
ATE188129T1 (de)	2000-01-15	Ipriflavone enthaltende pharmazeutische zubereitungen und deren verwendung zur ersetzung von knochendefekten
NO913683L (no)	1992-03-23	Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
AU561584B2 (en)	1987-05-14	Paste for haemostasis and temporary bridging of defects in cases of bone trauma
AU8452791A (en)	1992-03-26	1-phenyl-3-aryl-2-propyne-1-ones
EP0348664A3 (de)	1990-11-07	Monoacetoacetine enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Tumoren
UA37211C2 (uk)	2001-05-15	Похідні 1,4-дигідропіридину у формі рацемату або енантіомерів, 2-хлор-3-ціанобензальдегід як проміжний продукт для їх одержання та фармацевтична композиція, що має антагоністичну активність по відношенню до катіонів кальцію